VolitionRx Limited Cash and Restricted Cash
VolitionRx Limited (VNRX) had Cash and Restricted Cash of $2.79 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.79M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.10M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.12M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $199.41K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $2.79M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $199.41K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.26M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $2.60M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $3.26M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $5.41M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $6.00M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $11.77M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $20.73M 10-K · filed 2026-03-31 |
| 2023-09-30 | $10.81M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $19.74M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $10.01M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $10.87M 10-K · filed 2025-03-31 |
| 2022-09-30 | $16.42M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $16.73M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $23.73M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $20.58M 10-K · filed 2024-03-25 |
| 2021-09-30 | $22.90M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $27.91M 10-Q · filed 2022-08-10 |
| 2020-12-31 | $19.44M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |